Free continuing education activities designed for nurses and nurse practitioners in clinical practice.

An Evidence-Based Approach to Managing Chemotherapy-Induced Nausea and Vomiting
This continuing education activity is designed for nurses and nurse practitioners in clinical practice to learn about the assessment, prevention and control of chemotherapy-induced nausea and vomiting (CINV). This activity has been approved for 1.0 contact hour (and 0.75 pharmacology hours).

Nursing Management of the Patient with Bone Metastases
Continuing Education Information This free continuing education activity is designed for nurses in clinical practice to learn about the nursing management and treatment of patients with bone metastases. This activity has been approved for 1.1...

Continuing medical education (CME) programs, delivered by world-renowned experts in their fields, sponsored by QuantiaMD.

Chronic Myeloid Leukemia: Clinical Practices for effective Treatment
Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the blood stem cells that accounts for approximately 15% of all adult leukemias. Recent changes to standard therapy, combined with the development of novel CML agents, have led to challenges with regard to escalation and transition of therapy and management of treatment-related side effects. This continuing education activity will improve the ability of oncologists and other clinicians to treat and manage CML through application of contemporary CML guidelines and utilization of novel CML therapies.

Non-Hodgkin's Lymphoma: Current Strategies, Ongoing Challenges, and Future Treatments in Follicular Lymphoma
Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignancy in adults, and the sixth most common cancer diagnosed in the United States each year.

Continuing Medical Education (CME) activities sponsored by the University of Pennsylvania.

Latest Advances in the Diagnosis and Treatment of Malignant Gliomas
When patients present with neurological or cognitive deficits indicating a possible brain tumor, crucial decisions must be made to produce an accurate diagnosis, effective treatment plan, and hopeful prognosis. This multidisciplinary educational activity outlines the latest innovative approaches to treat patients with newly diagnosed tumors. This module is designed for radiologists, neuro-surgeons, neuro-oncologists, radiation oncologists, medical oncologists, and other healthcare professionals interested in the treatment of gliomas.

Take as Directed: Improving Adherence with Oral Anticancer Agents - An Interdisciplinary Approach
This activity is intended for oncologists, nurses, pharmacists, and other healthcare professionals who care for patients with cancer as well as cancer survivors. The goal of this activity is to improve communication between members of the cancer care team and patients about adherence with oral anticancer regimens.